Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Emory University
With
Radiation Therapy Oncology Group
Concurrent chemoradiation is the standard of care for locally advanced squamous cell carcinoma of the head and neck (SCCHN). Improving the outcome for patients with this disease remains a major challenge.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Biopsy proven squamous cell carcinoma of the head and neck (SCCHN)
Primary disease site involving the oropharynx
Clinical stage III or IV
Age ≥ 18
Karnofsky Performance Status (KPS) ≥ 70
Adequate bone marrow, kidney, and hepatic function (no laboratory value \> 2 times the normal limit)
Amylase (0-160 U/L) and lipase (0-130 U/L) levels within 1.5 times the range of normal
You may not be if
Prior history of SCCHN
Prior history of radiation to the head and neck region
KPS \< 70
Soy allergy
Contraindication to cisplatin chemotherapy or plans to alter or reduce cisplatin therapy
Any head and neck cancer of non-squamous histology
Any head and neck subsite other than oropharynx (including unknown primary site)
